GlassScriptPhysician profile
Mohammad A Kazmi
NPI 1306848460
$24,517.85
in general payments reported to CMS, 2019-2025
82 companies · $5,051 in 2025
The $5,051 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,701 · 2020: $1,818 · 2021: $2,691 · 2022: $4,644 · 2023: $3,284 · 2024: $4,329 · 2025: $5,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $5.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,657.72 |
| Education | $5.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,422.95 | 2021-2025 | |
| Ucb, INC. | $2,161.28 | 2019-2025 | Fintepla, Zilbrysq, Briviact |
| Biogen, INC. | $1,296.84 | 2020-2025 | Vumerity, Tysabri, Leqembi |
| Sk Life Science, INC. | $1,044.82 | 2020-2025 | Xcopri |
| Neurocrine Biosciences, INC. | $877.22 | 2021-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $871.92 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Amneal Pharmaceuticals LLC | $764.99 | 2019-2025 | Rytary, Crexont, Ongentys |
| Acadia Pharmaceuticals INC | $752.72 | 2019-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $722.67 | 2019-2025 | Ultomiris, Strensiq, Soliris |
| Genzyme Corporation | $707.44 | 2019-2025 | |
| Emd Serono, INC. | $626.14 | 2019-2025 | Mavenclad, Mavenclad |
| Amgen INC. | $621.93 | 2019-2025 | Uplizna, Tepezza |
| Mdd US Operations, LLC | $588.04 | 2019-2024 | Gocovri |
| Pfizer INC. | $582.17 | 2022-2025 | |
| Eisai INC. | $575.97 | 2020-2025 |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $568.49 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $480.98 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $441.99 | 2019-2023 | Austedo, Austedo Xr |
| Medtronic USA, INC. | $434.46 | 2019 | |
| Neurelis, INC. | $425.52 | 2020-2025 | Valtoco |
| Livanova USA, INC. | $405.02 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Argenx US, INC. | $401.87 | 2022-2025 | Vyvgart Hytrulo |
| Otsuka America Pharmaceutical, INC. | $394.56 | 2023-2025 | Rexulti, Nuedexta |
| Impel Pharmaceuticals INC. | $356.84 | 2022-2023 | Trudhesa |
| Biohaven Pharmaceutical Holding Company LTD. | $327.40 | 2022 | |
| Aucta Pharmaceuticals, INC. | $305.42 | 2024-2025 | Motpoly Xr |
| Lundbeck LLC | $279.86 | 2019-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $275.96 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $269.00 | 2019-2025 | Spravato |
| Genentech USA, INC. | $261.80 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Sanofi-Aventis U.S. LLC | $227.68 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $212.80 | 2022-2025 | Xeomin, Inbrija |
| Acorda Therapeutics, INC | $207.25 | 2019-2023 | Inbrija, Ampyra |
| Jazz Pharmaceuticals INC. | $203.55 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $198.69 | 2023-2025 | Hyqvia |
| Abbott Laboratories | $198.26 | 2019-2025 | Freestyle Libre 3 |
| Celgene Corporation | $176.62 | 2021-2024 | Zeposia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.75 | 2019-2024 | Jardiance |
| Ge Healthcare | $161.44 | 2022-2025 | |
| Avanir Pharmaceuticals, INC. | $157.92 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $149.59 | 2020-2021 | |
| Horizon Therapeutics Plc | $135.70 | 2022-2023 | Uplizna |
| Janssen Biotech, INC. | $134.09 | 2025 | |
| Grifols USA, LLC | $116.26 | 2022-2025 | Gamunex-C |
| Sunovion Pharmaceuticals INC. | $109.94 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $107.38 | 2024-2025 | Hetlioz, Fanapt, Ponvory |
| Catalyst Pharmaceuticals, INC. | $104.77 | 2023 | Fycompa, Firdapse |
| Adamas Pharmaceuticals, INC. | $101.07 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $100.48 | 2022-2025 | Purified Cortrophin Gel |
| Greenwich Biosciences, INC. | $96.88 | 2019-2021 | |
| Banner Life Sciences, LLC | $91.27 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.24 | 2021-2025 | |
| Tanabe Pharma America, INC. | $81.02 | 2024-2025 | Radicava |
| Novo Nordisk INC | $80.17 | 2021-2023 | Rybelsus, Ozempic |
| Kyowa Kirin, INC. | $79.76 | 2022-2024 | Crysvita, Nourianz |
| Csl Behring | $74.62 | 2023-2024 | Hizentra |
| Medtronic, INC. | $69.71 | 2022-2024 | Minimed 780g |
| Corcept Therapeutics | $54.35 | 2025 | Korlym |
| Biotissue Holdings INC. | $48.31 | 2022-2023 | |
| Akcea Therapeutics, INC. | $45.33 | 2019 | |
| Octapharma USA, INC. | $40.38 | 2023-2024 | Panzyga |
| E.R. Squibb & Sons, L.L.C. | $34.60 | 2020-2021 | |
| Tg Therapeutics, INC. | $34.05 | 2025 | |
| Averitas Pharma INC. | $29.06 | 2024 | Qutenza |
| Sumitomo Pharma America, INC. | $27.76 | 2023 | Aptiom |
| Shire North American Group INC | $27.50 | 2019 | |
| Idorsia Pharmaceuticals US INC | $26.75 | 2023 | Quviviq |
| Becton, Dickinson and Company | $26.72 | 2021 | |
| Portola Pharmaceuticals, LLC | $26.02 | 2019 | |
| Azurity Pharmaceuticals, INC. | $21.49 | 2025 | Zonisade |
| Cala Health, INC. | $21.21 | 2023 | Cala Kiq, Cala Trio |
| Ceribell, INC. | $19.18 | 2020 | |
| Kedrion Biopharma, INC. | $18.97 | 2024 | Koate, Albuked, Kedrab |
| Silk Road Medical, INC. | $18.79 | 2019 | |
| Neuropace, INC. | $18.54 | 2024 | |
| Rgh Enterprises LLC | $16.38 | 2025 | |
| Dexcom, INC. | $16.33 | 2021 | |
| Merz North America, INC. | $15.80 | 2019 | |
| Impel Pharmaceuticals LLC | $15.74 | 2024 | Trudhesa |
| Cequr Corporation | $14.18 | 2022 | |
| Microtransponder, INC. | $14.04 | 2025 | |
| Boston Scientific Corporation | $13.19 | 2019 |
Drugs and devices associated with these payments
Qulipta $935Ubrelvy $865Ingrezza $630Fintepla $544Rexulti $525Nurtec Odt $518Zavzpret $497Gocovri $479Vumerity $412Tysabri $393Leqembi $383Ultomiris $354Botox $338Zilbrysq $322Vns Therapy Sentiva Model 1000 Generator $314Motpoly Xr $305Valtoco $299Rytary $267Vyvgart Hytrulo $264Nuplazid $246Uplizna $242Mavenclad $222Briviact $199Nayzilam $192Ongentys $188Trudhesa $183Epidiolex $182Hyqvia $168Kisunla $148Strensiq $148Zeposia $133Ocrevus $125Xeomin $123Amyvid $109Soliris $107Paxlovid $102Jardiance $101Rystiggo $98.91Hetlioz $90.94Fanapt $90.94Enspryng $87.12Gamunex-C $82.58Kesimpta $82.12Radicava $81.02Emgality $76.84Purified Cortrophin Gel $75.62Hizentra $74.62Duopa $73.94Crexont $66.69Panzyga $62.82Fycompa $61.46Kerendia $61.44Korlym $54.35Radicava Ors $50.77Bafiertam $49.85Tepezza $46.57Inbrija $46.37Minimed 780g $45.42Firdapse $43.31Ocrevus Zunovo $42.91Vraylar $40.43Vyalev $34.50Comirnaty $34.47Briumvi $34.05Zepbound $33.21Aubagio $32.10Qutenza $29.06Aptiom $27.76Quviviq $26.75Spravato $25.42Neox $25.34Clarix $25.34Freestyle Libre 3 $24.57Xcopri $23.61Ozempic $22.66Rybelsus $22.66Mounjaro $22.26Crysvita $22.24Nourianz $21.83Zonisade $21.49Skyclarys $21.40Cala Trio $21.21Cala Kiq $21.21Ampyra $21.19Reyvow $20.71Kedrab $18.97Koate $18.97Gammaked $18.97Albuked $18.97Rhogam Ultra-Filtered Plus $18.97Rns Neurostimulator Kit $18.54Mayzent $17.19Ponvory $16.44Nuedexta $15.51Austedo $14.28Austedo Xr $13.74
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Kazmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.